SCHEMBL20660920

SCHEMBL20660920

Cc1cc(-c2ccc3cc(F)ccc3n2)cnc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 1/20 0.49
▸ MAP4K4 O95819 6/20 0.44
▸ ABL1 P00519 2/20 0.40
▸ PTGDR2 Q9Y5Y4 1/20 0.39
▸ PIK3CA P42336 1/20 0.39
▸ NOS3 P29474 1/20 0.39
▸ NOS1 P29475 1/20 0.39
▸ NOS2 P35228 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MAOB P27338 3/20 0.38
▸ MAOA P21397 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ESR1 P03372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20660565 0.81 BACE1 (0.50) BACE1MAP4K4ABL1MAPTMAOB
SCHEMBL13399634 0.79 NPC1 (0.46) BACE1MAP4K4ABL1MAPTMAOB
SCHEMBL20660528 0.76 BACE1 (0.51) BACE1MAP4K4ABL1PIK3CANOS3
SCHEMBL20660566 0.76 BACE1 (0.47) BACE1MAP4K4ABL1MAPTKDM4E
SCHEMBL13399631 0.75 BACE1 (0.49) BACE1MAP4K4MAPTMAOBMAOA
SCHEMBL20671100 0.73 BACE1 (0.41) BACE1MAP4K4MAPTMAOBMAOA
SCHEMBL20660721 0.73 BACE1 (0.54) BACE1MAPTMAOBMAOAKDM4E
SCHEMBL15831577 0.73 CCR1 (0.52) BACE1MAOBKDM4ENPC1ALDH1A1
SCHEMBL20660767 0.72 BACE1 (0.50) BACE1ABL1MAPTMAOBMAOA
SCHEMBL15831599 0.72 BACE1 (0.42) BACE1MAP4K4ABL1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 — — US disclosed
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 — — US disclosed
US-20220340875-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. 2022-10-27 — — US disclosed
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2021-04-22 — — US disclosed
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2021-04-22 — — US disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 — — WO disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 — — WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 — — WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220340875-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS AHR, MCL1, ARNT BACE1 2063/4885MAP4K4 3584/4885ABL1 682/4885
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS AHR, ARNT, RXRB BACE1 958/4885MAP4K4 3510/4885ABL1 1622/4885
US-11548867-B2 Amido compounds as AhR modulators AHR, ARNT, RXRB BACE1 958/4885MAP4K4 3510/4885ABL1 1622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback